What Does Revolution Medicines Do?

Total employees626
HeadquartersRedwood City
Founded2014

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. Their research and development efforts are centered on creating therapies that selectively target and inhibit cancer-driving proteins, particularly those within the RAS and mTOR signaling pathways. They aim to transform cancer treatment by designing drugs against previously intractable targets. Their pipeline includes multiple programs in various stages of clinical development, leveraging their proprietary TRIPOD platform for drug discovery.

Where Is Revolution Medicines's Headquarters?

HQ Function

Serves as the primary hub for research and development, corporate operations, clinical development, and strategic planning for the company's oncology programs.

Notable Features:

State-of-the-art laboratory facilities designed for advanced cancer research, including drug discovery and translational medicine. Collaborative workspaces fostering innovation among scientific and corporate teams.

Work Culture:

A science-driven, innovative, and collaborative environment. Employees are typically mission-focused on advancing cancer treatments. The culture emphasizes teamwork, scientific rigor, and a fast-paced approach to drug development.

HQ Significance:

Located in the San Francisco Bay Area, a prominent global hub for biotechnology and pharmaceutical innovation, providing access to a rich talent pool, research institutions, and venture capital.

Values Reflected in HQ: The headquarters reflects a commitment to scientific excellence, innovation, and efficiency in pursuit of developing transformative cancer therapies.

Location:

While its primary physical offices are in the United States (Redwood City, CA and Cambridge, MA), Revolution Medicines operates with a global perspective, particularly in its clinical trial activities. The company conducts clinical studies across North America, Europe, and Asia-Pacific to evaluate its investigational therapies in diverse patient populations. Their drug development programs aim to address cancer, a global health issue.

Street Address:

700 Saginaw Drive

City:

Redwood City

State/Province:

CA

Country:

USA

Where Else Does Revolution Medicines Operate Around the World?

Cambridge, MA, USA

Address: One Kendall Square, Building 1400W, Suite 14-102, Cambridge, MA 02139

Facilitates engagement with the Boston/Cambridge biotech hub, supporting research collaborations, clinical trial operations, and access to key opinion leaders in oncology.

Buying Intent Signals for Revolution Medicines

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Revolution Medicines? Meet the Executive Team

As of April 2025, Revolution Medicines' leadership includes:

Mark A. Goldsmith, M.D., Ph.D. - Chief Executive Officer and Chairman
Stephen G. Kelsey, M.D. - President, Head of Research and Development
Jack F. Anders - Chief Financial Officer
Wei Lin, M.D. - Chief Medical Officer
Margaret A. Horn, J.D. - Chief Operating Officer, General Counsel and Secretary
Xiaolin Wang, Ph.D. - Chief Technology Officer
Jeff P. Winton - Chief People and Culture Officer

Who's Investing in Revolution Medicines?

Revolution Medicines has been backed by several prominent investors over the years, including:

The Column Group
Nextech Invest
Third Rock Ventures
Casdin Capital
Boxer Capital (Tavistock Group)
Fidelity Management & Research Company LLC
BlackRock
RA Capital Management
Biotechnology Value Fund (BVF Partners)
Logos Capital

What Leadership Changes Has Revolution Medicines Seen Recently?

Hire2
Exits0

In the past year, Revolution Medicines has seen key appointments strengthening its leadership, notably with Jack F. Anders taking on the CFO role and Jeff P. Winton joining as Chief People and Culture Officer. There have been no major publicly announced executive departures.

New Appointments:

Jack F. Anders, Jack F. Anders appointed as new Chief Financial Officer.
Jeff P. Winton, Jeff P. Winton appointed as new Chief People and Culture Officer.

What Technology (Tech Stack) Is Used byRevolution Medicines?

Discover the tools Revolution Medicines uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Revolution Medicines Email Formats and Examples

Revolution Medicines most commonly uses the email format combining the first initial and last name. Other formats might exist but are less common.

flast@revmed.com

Format

jdoe@revmed.com

Example

85%

Success rate

What's the Latest News About Revolution Medicines?

GlobeNewswireJuly 16, 2024

Revolution Medicines Reports Initial Clinical Data for RMC-6236 (RASMULTI(ON) Inhibitor) in Patients with KRAS G12D Mutant Pancreatic Cancer

Revolution Medicines announced initial clinical data from the Phase 1/1b trial of RMC-6236 in patients with KRAS G12D mutant pancreatic ductal adenocarcinoma (PDAC). The data show encouraging anti-tumor activity and a manageable safety profile....more

GlobeNewswireMay 21, 2024

Revolution Medicines Announces Presentation of Preclinical Data for RMC-9805, its Mutant-Selective PI3Kα(ON) Inhibitor, at 2024 ASCO Annual Meeting

Revolution Medicines announced it would present preclinical data for RMC-9805, its first-in-class, mutant-selective PI3Kα(ON) inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. The data highlights its differentiated mechanism and potential for treating PIK3CA-mutant cancers....more

GlobeNewswireMay 7, 2024

Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress

Revolution Medicines provided a corporate update and reported financial results for the first quarter ended March 31, 2024. The company highlighted progress across its pipeline of RAS(ON) inhibitors and other oncology programs....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Revolution Medicines, are just a search away.